- Ghana is to soon start a pilot of the world's first malaria vaccine
- Ghana is part of Kenya and Malawi to test the vaccine
- A successful pilot will see Ghana inch closer to combating malaria
Very soon you will not be visiting the hospital to treat malaria. This is because Ghana will soon start a test trial of malaria vaccines across the country.
This is going to be the world's first malaria vaccine and will include other African countries as Kenya and Malawi.
YEN.com.gh is learning that this malaria vaccine is called MosquirixTM and its function is to act against the malaria parasite called Plasmodium Falciparum - the most deadly malaria parasite in Africa and across the world.
The aim of this trial test is to is to find out how much doses the vaccine should provide and also the impact of the vaccine on lives saved, and the safety of the vaccine in the context of routine use.
"Although the figure from 2016 represents an improvement over that of 2015, we recognize that a lot of work has to be done in reducing the prevalence of malaria to the barest minimum," Ghanaian President Nana Addo Dankwa Akufo-Addo said at a Malaria Summit in London recently.
Meanwhile, Kezia Malm, Manager of the National Malaria Control Program (NMCP), said Ghana was selected for the trial because of its high malaria burden and well-functioning malaria and immunization programs.
Malaria is a dreaded disease which kills more children than any other disease and is the leading cause of miscarriage and stillbirths in pregnant women in Ghana. Should the pilot program be successful, Ghana will succeed in cutting down on malaria infections by 75 percent before the end of 2020.
Watch the trending news on YEN.com.gh this week: